home / stock / ikt / ikt news

IKT News and Press, Inhibikase Therapeutics Inc. From 05/09/24

Stock Information
Company Name: Inhibikase Therapeutics Inc.
Stock Symbol: IKT
Market: NASDAQ
Website: inhibikase.com
Menu
IKT IKT Quote IKT Short IKT News IKT Articles IKT Message Board
Get IKT Alerts

News, Short Squeeze, Breakout and More Instantly...
IKT - Inhibikase Therapeutics Announces Final Pre-IND Meeting Outcomes for IkT-001Pro as a Treatment for Pulmonary Arterial Hypertension

- FDA indicated IkT-001Pro can be considered a New Molecular Entity and is eligible for exclusivity designations in Pulmonary Arterial Hypertension – BOSTON and ATLANTA, May 09, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or &#...
IKT - US Companies Moving the Markets, Evening edition
Mon, Apr 22, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States AGBA Group Holding Limited (AGBA) rose 100.0% to $2.5 on volume of 201,539,290 shares PROSHARES TRUST (SQQQ) fell 2.9% to $12.47 on volume of 154,254,858 shares Tesla Inc. (TSLA) fell 3.4% to $142.05 on volume of 106,267,579 shares ...

IKT - MRIN, WISA and SMFL among mid-day movers

2024-04-22 12:52:14 ET More on Mid-day movers & stocks. Marin Software Incorporated (MRIN) Q4 2023 Earnings Call Transcript WiSA signs its fifth WiSA E licensing deal with major consumer electronics company WiSA jumps on announcing fourth HDTV/PTV license with ma...

IKT - US Companies Moving the Markets, Morning edition
Mon, Apr 22, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Moolec Science SA (MLEC) rose 85.7% to $2.6 on volume of 50,077,650 shares SuperCom Ltd. (SPCB) rose 46.0% to $0.3212 on volume of 37,315,721 shares AGBA Group Holding Limited (AGBA) rose 35.2% to $1.69 on volume of 26,672,582 shares ...
IKT - Inhibikase Therapeutics files to sell common stock, warrants

2024-04-19 17:26:48 ET More on Inhibikase Therapeutics Seeking Alpha’s Quant Rating on Inhibikase Therapeutics Historical earnings data for Inhibikase Therapeutics Financial information for Inhibikase Therapeutics Read the full article on Seeking Alp...

IKT - Inhibikase Therapeutics Announces Pre-IND Meeting with the FDA for IkT-001Pro in Pulmonary Arterial Hypertension

BOSTON and ATLANTA, April 03, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkins...

IKT - Inhibikase Therapeutics, Inc. (IKT) Q4 2023 Earnings Call Transcript

2024-03-28 17:13:08 ET Inhibikase Therapeutics, Inc. (IKT) Q4 2023 Earnings Call Transcript March 28, 2024 08:00 AM ET Company Participants Alex Lobo - Stern Investor Relations Milton Werner - CEO Garth Lees-Rolfe - CFO Conference Call Participants ...
IKT - Inhibikase Therapeutics GAAP EPS of -$3.57 misses by $0.82, revenue of $0.26M in-line

2024-03-27 16:44:45 ET More on Inhibikase Therapeutics Seeking Alpha’s Quant Rating on Inhibikase Therapeutics Historical earnings data for Inhibikase Therapeutics Financial information for Inhibikase Therapeutics Read the full article on Seeking Alp...

IKT - Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Activity

BOSTON and ATLANTA, March 27, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase or Company), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson’s disease (“PD”), Parkinson&#...

IKT - Inhibikase Therapeutics to Provide Trial Update for Risvodetinib at the 2024 International Conference on Alzheimer's and Parkinson's Diseases and Related Neurological Disorders

BOSTON and ATLANTA, March 07, 2024 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease, Parkins...
Previous 10 Next 10